InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

22 March 2026

Name:	NEXT SCIENCE LIMITED (NXS)
ISIN:	AU0000041329
Date of Listing:	18 April 2019
Date of Delisting:	10 February 2026

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 10 February 2026.

Legal Status: (updated monthly)

ACN: 622 382 549ABN: 47 622 382 549
Registration Date: 20 October 2017

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

NEXT SCIENCE LIMITED(NXS)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of NXS:

(3 out of 5)

COMPANY WEBSITE:

NXS website

NXS email

NXS investorRelations

NXS directors

REGISTRY:

Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001

Tel : 1300 288 664 or +61 2 9698 5414
Fax : +61 2 8583 3040
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000041329

Address: HWL Ebsworth Level 14, Australia Square 264-278 George Street Sydney NSW 2000
Tel: +61 2 8607 5124 Fax:

Date first listed: 18/04/2019
Company Secretary:
Sector: Health Care Equipment & Services Industry Group:
Activities: Commercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections

News & Events

Expand this box to read and print

delisted at entity's request under Listing Rule 17.11	10/02/2026
we understand the Company completed the sale of substantially all the assets of Next Science and its wholly-owned subsidiaries ("NXS Group") to OSARTIS GmbH, a Demetra company on 15 September 2025 and made a cash return of capital payment of $0.145 cash per share on 10 February 2026. (NXS is engaging with the ATO to confirm the income tax consequences of the Capital Return)	10/02/2026
The company confirms the cash return of capital payment announced on 30 January 2026 has been made on 10 February 2026. The Company has requested ASX for voluntary delisting, effective 11 February 2026, having met ASX conditions.	09/02/2026
The company lodges an update of its notice of cash return of capital.	02/02/2026
The company announces an amendment to its cash return of capital payment date. The new payment date is set for Tuesday, 10 February 2026. A revised Appendix 3A.4 has been released today, which retains all other details from the prior announcement made on 28 January 2026.	30/01/2026
The company lodges its notice of cash return of capital.	28/01/2026
The company releases the voting results of its general meeting.	28/01/2026
The company lodges its quarterly activity report and appendix 4C for December 2025.	28/01/2026
The company will face a suspension of its securities from quotation starting Friday, 2 January 2026, according to Listing Rule 17.3.1, following a six-month period to sell its main undertaking. ASX monitored NXS's operational sufficiency for continued quotation under Listing Rule 12.1 but determined that NXS lacks adequate operations. The suspension remains in effect until ASX is assured that NXS meets all Listing Rules requirements for reinstatement.	02/01/2026
listed entity carried for record purposes only	18/04/2019

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
30/03/2022	Judith Mitchell	-140,000	$0.881	$123,310.00
24/11/2020	Judith Mitchell	67,362	$1.140	$76,793.00
24/11/2020	Bruce Hancox	130,000	$1.149	$149,344.00
29/10/2020	Judith Mitchell	188,200	$1.150	$216,430.00
28/10/2020	Bruce Hancox	30,000	$1.160	$34,800.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Aileen Stockburger	Chairman	18/10/2018
Grant Hummel	Independent Director	23/08/2023
Katherine Ostin	Independent Director	24/10/2023
Gillian Nairn	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.